Age: 28 Collected: 11/12/2019 11:16

Sex: F Fasting: N Received: 11/12/2019 11:17

Reported: 11/15/2019 09:57

FASTING:NO

THYROID PEROXIDASE AND THYROGLOBULIN ANTIBODIES

Analyte Value

THYROGLOBULIN ANTIBODIES 135 H Reference Range: < or = 1 IU/mL

THYROID PEROXIDASE ANTIBODIES 103 H Reference Range: <9 IU/mL

LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT

Analyte Value

LYME DISEASE AB(IGG),BLOT NEGATIVE Reference Range: NEGATIVE

18 KD (IGG) BAND NON-REACTIVE

23 KD (IGG) BAND NON-REACTIVE

28 KD (IGG) BAND NON-REACTIVE

30 KD (IGG) BAND NON-REACTIVE

39 KD (IGG) BAND NON-REACTIVE

41 KD (IGG) BAND REACTIVE

45 KD (IGG) BAND NON-REACTIVE

58 KD (IGG) BAND NON-REACTIVE

66 KD (IGG) BAND NON-REACTIVE

93 KD (IGG) BAND NON-REACTIVE

LYME DISEASE AB(IGM),BLOT NEGATIVE Reference Range: NEGATIVE

23 KD (IGM) BAND REACTIVE

39 KD (IGM) BAND NON-REACTIVE

41 KD (IGM) BAND NON-REACTIVE

As per CDC criteria, a Lyme disease IgG Immunoblot must
show reactivity to at least 5 of 10 specific borrelial
proteins to be considered positive; similarly, a
positive Lyme disease IgM immunoblot requires
reactivity to 2 of 3 specific borrelial proteins.
Although considered negative, IgG reactivity to fewer
specific borrelial proteins or IgM reactivity to only
1 protein may indicate recent B. burgdorferi infection
and warrant testing of a later sample. A positive IgM
but negative IgG result obtained more than a month
after onset of symptoms likely represents a false-
positive IgM result rather than acute Lyme disease.
In rare instances, Lyme disease immunoblot reactivity
may represent antibodies induced by exposure to other
spirochetes.

COMMENT
Lyme immunoblot testing should only be performed on
samples from patients who have had a Positive or
Equivocal result in a screening assay.

1/5 11/15/19
COMPREHENSIVE METABOLIC PANEL
Analyte Value

GLUCOSE 87 Reference Range: 65-139 mg/dL

Non-fasting reference interval

UREA NITROGEN (BUN) 19 Reference Range: 7-25 mg/dL

CREATININE 0.51 Reference Range: 0.50-1.10 mg/dL

eGFR NON-AFR. AMERICAN 131 Reference Range: > OR = 60 mL/min/1.73m2

eGFR AFRICAN AMERICAN 152 Reference Range: > OR = 60 mL/min/1.73m2

BUN/CREATININE RATIO NOT APPLICABLE Reference Range: 6-22 (calc)

SODIUM 138 Reference Range: 135-146 mmol/L

POTASSIUM 4.2 Reference Range: 3.5-5.3 mmol/L

CHLORIDE 102 Reference Range: 98-110 mmol/L

CARBON DIOXIDE 27 Reference Range: 20-32 mmol/L

CALCIUM 9.5 Reference Range: 8.6-10.2 mg/dL

PROTEIN, TOTAL 7.0 Reference Range: 6.1-8.1 g/dL

ALBUMIN 4.2 Reference Range: 3.6-5.1 g/dL

GLOBULIN 2.8 Reference Range: 1.9-3.7 g/dL (calc)

ALBUMIN/GLOBULIN RATIO 1.5 Reference Range: 1.0-2.5 (calc)

BILIRUBIN, TOTAL 0.4 Reference Range: 0.2-1.2 mg/dL

ALKALINE PHOSPHATASE 49 Reference Range: 33-115 U/L

AST 14 Reference Range: 10-30 U/L

ALT 12 Reference Range: 6-29 U/L

T3 REVERSE, LC/MS/MS
Analyte Value

T3 REVERSE, LC/MS/MS 15 Reference Range: 8-25 ng/dL

This test was developed and its analytical performance
characteristics have been determined by Quest
Diagnostics Nichols Institute Chantilly, VA. It has
not been cleared or approved by the U.S. Food and Drug
Administration. This assay has been validated pursuant
to the CLIA regulations and is used for clinical
purposes.

CBC (H/H, RBC, INDICES, WBC, PLT)

Analyte Value

WHITE BLOOD CELL COUNT 6.5 Reference Range: 3.8-10.8 Thousand/uL

RED BLOOD CELL COUNT 4.54 Reference Range: 3.80-5.10 Million/uL

HEMOGLOBIN 13.3 Reference Range: 11.7-15.5 g/dL

HEMATOCRIT 40.7 Reference Range: 35.0-45.0 %

MCV 89.6 Reference Range: 80.0-100.0 fL

MCH 29.3 Reference Range: 27.0-33.0 pg

MCHC 32.7 Reference Range: 32.0-36.0 g/dL

2/5 11/15/19
RDW 11.8 Reference Range: 11.0-15.0 %

PLATELET COUNT 272 Reference Range: 140-400 Thousand/uL

MPV 10.5 Reference Range: 7.5-12.5 fL

GLIADIN (DEAMIDATED) AB (IGG, IGA)

Analyte Value

GLIADIN (DEAMIDATED) AB (IGA) 3 Units See Note 1

GLIADIN (DEAMIDATED) AB (IGG) 3 Units See Note 1

TISSUE TRANSGLUTAMINASE ANTIBODY, IGG,IGA

Analyte Value

TISSUE TRANSGLUTAMINASE AB, IGG 2 U/mL

Value Interpretation
----- --------------
<6 No Antibody Detected
> or = 6 Antibody Detected

TISSUE TRANSGLUTAMINASE AB, IGA 1 U/mL

Value Interpretation
----- --------------
<4 No Antibody Detected
> or = 4 Antibody Detected

RHEUMATOID FACTOR
Analyte Value

RHEUMATOID FACTOR <14 Reference Range: <14 IU/mL

ANA MULTIPLEX W/REFLEX 11 AB CASCADE

Analyte Value

ANACHOICE® SCREEN NEGATIVE Reference Range: NEGATIVE

A negative ANA Multiplex, with Reflex to 11 Antibody
Cascade indicates the absence of detectable antibodies
to component analytes consisting of double stranded DNA
(dsDNA), chromatin, ribonucleoprotein (RNP), Smith/RNP
(Sm/RNP), Smith (Sm), SS-A, SS-B, Jo-1, centromere B,
Scl-70 and ribosomal P.

A negative result should be interpreted in the context

of the clinical and laboratory findings and does not
rule out autoimmune disease characterized by other
autoantibody specificities such as rheumatoid
arthritis, autoimmune hepatitis, primary biliary
cirrhosis, autoimmune thyroiditis, Addison's disease,
pernicious anemia, autoimmune neuropathies, vasculitis,
celiac disease, and bullous disease.

For additional information, please refer to

http://education.QuestDiagnostics.com/faq/FAQ177
(This link is being provided for informational/
educational purposes only.)

INSULIN
Analyte Value

3/5 11/15/19
INSULIN 14.6 Reference Range: 2.0-19.6 uIU/mL
This insulin assay shows strong cross-reactivity for
some insulin analogs (lispro, aspart, and glargine)
and much lower cross-reactivity with others (detemir,
glulisine).

T3, TOTAL
Analyte Value

T3, TOTAL 90 Reference Range: 76-181 ng/dL

CORTISOL, A.M.
Analyte Value

CORTISOL, A.M. 5.3 mcg/dL

Reference Range
8 a.m. (7-9 a.m.) Specimen: 4.0-22.0

TSH W/REFLEX TO FT4

Analyte Value

TSH W/REFLEX TO FT4 1.14 mIU/L

Reference Range

> or = 20 Years 0.40-4.50

Pregnancy Ranges
First trimester 0.26-2.66
Second trimester 0.55-2.73
Third trimester 0.43-2.91

HEMOGLOBIN A1c
Analyte Value

HEMOGLOBIN A1c 5.4 Reference Range: <5.7 % of total Hgb

For the purpose of screening for the presence of
diabetes:

<5.7% Consistent with the absence of diabetes

5.7-6.4% Consistent with increased risk for diabetes
(prediabetes)
> or =6.5% Consistent with diabetes

This assay result is consistent with a decreased risk

of diabetes.

Currently, no consensus exists regarding use of

hemoglobin A1c for diagnosis of diabetes in children.

According to American Diabetes Association (ADA)

guidelines, hemoglobin A1c <7.0% represents optimal
control in non-pregnant diabetic patients. Different
metrics may apply to specific patient populations.
Standards of Medical Care in Diabetes(ADA).

Note 1 Value Interpretation

----- --------------
<20 Antibody not detected
>or=20 Antibody detected

Performing Sites
AMD Quest Diagnostics/Nichols Chantilly-Chantilly VA, 14225 Newbrook Drive, Chantilly, VA 20153-0841 Laboratory Director: Patrick W Mason
M.D.,PhD
NL2 Quest Diagnostics Massachusetts LLC-Quest Diagnost, 200 Forest St, 3Rd Fl, Marlborough, MA 01752-3023 Laboratory Director: Salim E
4/5 11/15/19